News you won't see in controlled mainstream media.

Circle-of-Life Forums - Welcome
Open-Source News, Natural Health, Recipes, Freedom, Preparedness, Computers, Technology, Movies, Reviews, History, Wisdom, Truth
See All Social Media We Are On | Trouble viewing videos? Use FireFox instead of Chrome.
Mercury Detox & Amalgam Fillings Forum

The Mercury Detox & Amalgam Fillings Forum

Detoxing Heavy Metals, Removing Amalgam Fillings, Understanding Mercury Poisoning

Our Most Popular Videos, Audio Clips, and Articles

Text
Text

2,115,526

views

Secret News
News you won't hear in controlled mainstream media.
Video Document
Video

74,694

views

CFL Bulbs: Are They Safe?
An experiment exposing the serious danger of compact fluorescent bulbs.
Video Document
Video

2,762

views

Mercury From Canned Fish Contaminating Your Kitchen
Open a can of fish and you begin breathing mercury vapor.
Website
Website

(remote)

views

Spraying the Skies with Toxic Metals
Have you heard about the epic crime of human history?
Video
Video

84,127

views

The Global Depopulation Agenda Documented
A MUST-SEE lecture for every parent!
Video
Video

77,191

views

What In the World are They Spraying?
Vaccination via the air for everyone, every day!
Video
Video

9,690

views

The
A 2-minute explanation of the global warming lie.
Video
Video

6,441

views

Global Warming: The Other Side
The Weather Channel founder exposes the GW lie.
Video
Video

19,134

views

Know Your Enemy
A revolutionary look at Earth history.
Video
Video

8,608

views

Mystery Babylon
The grandmother of all conspiracies.
Video
Video

1,694

views

The Power Behind the New World Order
An essential video for all wishing to understand.
Video
Video

4,284

views

Global Warming: Is CO2 the Cause
Dr. Robert Carter tells the truth about global warming.
Video
Video

1,160

views

All Jesse Ventura Conspiracy Theory Episodes In One Place
Easily find the episodes you want to watch.
Text
Text

28,478

views

New Study Steers Mercury Blame Away From Vaccines Toward Environment: But Where's It Coming From?
New study steers mercury blame away from vaccines.
Text
Text

39,214

views

Revelation 18:23 What does "sorcery" really mean?
Text
Text

29,509

views

The Leading Cause of Death Globally - Likely Has Been for Decades
Modern medicine leading cause of death globally?
Video
Video

21,668

views

Lies In the Textbooks - Full Version
Blatant, intentional lies in American textbooks.
Text
Text

13,001

views

Stop Chemical and Biological Testing on U.S. Citizens
Testing on U.S. Citizens is perfectly legal today.
Text
Text

14,262

views

Do Vaccines Cause Cancer? Cancerous Cell Lines Used in the Development of Vaccines
DOCUMENTED! Cancerous cell lines used in vaccines!
Video
Video

13,271

views

Italian Doctor - Dr. Tullio Simoncini - Reportedly Curing 90% of Cancer Cases
Italian Doctor makes history & gets license revoked.
Video
Video

19,401

views

Apollyon Rising 2012 - The Final Mystery Of The Great Seal Revealed: A Terrifying And Prophetic Cipher, Hidden From The World By The U.S. Government For Over 200 Years Is Here
The Final Mystery Of the Great Seal of the U.S. Revealed
Video
Video

9,938

views

Invisible Empire - New Epic Video about the New World Order
Epic Video about the New World Order.
Video
Video

12,150

views

The Lie of the Serpent: Dr. Walter Veith Examines the New Age Movement's Relationship to the New World Order
The New Age Movement & The New World Order
Video Document
Video

31,328

views

Secret News
Whitewater, drug smuggling, and the bloodiest campaign trail in history
Text Document
Text

15,057

views

Secret News
Professional actors in politics and media
Video Document
Video

4,496

views

Secret News
The biggest conspiracy of all: Keeping it all in the family
Text Document
Text

14,994

views

Secret News
Neuro Linguistic Programming (NLP): The language of politics
Video Document
Video

15,326

views

Secret News
Congressman Sherman tells it like it is; Is anyone listening?
Video Document
Video

17,644

views

Secret News
The only way to ensure privacy is to remove your cell phone battery
Video Document
Video

13,005

views

Secret News
Rep Kapture reveals epic crimes that remain unpunished
Video Document
Video

15,351

views

Secret News
The reason so many are sterile, sick and dying today
Video Document
Video

14,265

views

Secret News
Former U.S. Vice President Dick Cheney Says "No Evidence" for Bin Laden Involvement in 9-11
Video Document
Video

12,147

views

Secret News
The highest elected U.S. officials make sure they are exempt from justice.
Video Document
Video

13,100

views

Secret News
The murder of JFK cleared the way for the communist globalist agenda
Video Document
Video

3,105

views

Secret News
The world's largest military contractors exposed in "Iraq For Sale"
Video Document
Video

7,154

views

Secret News
A paradigm-changing video that everyone must see.
Video Document
Video

8,529

views

Secret News
This is a chilling video that exposes the use-or misuse-of the word "force" in HR1955
Video Document
Video

11,725

views

Secret News
A Hollywood producer told about 9/11 before it happened
Video Document
Video

5,380

views

Secret News
How many other news stories have been faked that we don't know about?
Video Document
Video

997

views

Secret News
Texas legislators on both sides of the iasle voting for each other
Video Document
Video

1,066

views

Secret News
Canadian Prime Minister Stephen Harper and Australian Prime Minister John Howard give the same speech
Video Document
Video

1,049

views

Secret News
Why are are few (not all) police working to promote hate and violence?
Text Document
Text

5,363

views

Secret News
New grassroots movement protects U.S. citizens against unlawful police action
Who's Online Now
1 registered members (Russ), 1,192 guests, and 25 spiders.
Key: Admin, Global Mod, Mod
ShoutChat Box
April
S M T W T F S
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30
Left Sidebar Ad
Popular Topics(Views)
338,555 DOES GOD EXIST?
253,814 Please HELP!!!
161,779 Open Conspiracy
106,414 History rules
98,543 Symmetry
87,658 oil pulling
Support Our Forum
Herbs/Nutrition
Only The Best HerbsOnly The Best Herbs!
Your best source of world-class herbal information! More...
Mercury Detox
Amalgam Illness: Diagnosis and Treatment by Dr. Andrew Cutler#1 Book We've Found!
"Silver" fillings, mercury detox, & much more. More...
Algin
AlginFor Mercury Detox
Prevent mercury reabsorption in the colon during detox. More...
Mercury Poisoning
DMSA, 25mg.Softcover & Kindle
Excellent resource for mercury detox. More...
DMSA 100mg
EDTA 500mg
DMSA, 25mg.For Mercury Chelation
For calcium chelation and heart health. More...
Vaccine Safety?
Vaccines: The Risks, The Benefits, The Choices by Dr. Sherri TenpennyMust for Every Parent
The most complete vaccine info on the planet. More...
Stop Candida!
Candida ClearFinally.
Relief! More...
Saying NO To Vaccines
Saying No To Vaccines by Dr. Sherri TenpennyDr. Sherri Tenpenny
Get the info you need to protect yourself. More...
Nano-Silver
Amalgam Illness: Diagnosis and Treatment by Dr. Andrew CutlerWhat everyone's talking about!
Safe, powerful, timely! More...
World's Best Vitamin E
Vitamin E wih SeleniumThere is a difference!
A powerful brain antioxidant for use during Hg detox. More...
It's All In Your Head
It's All In Your Head by Dr. Hal HugginsThis changed my life!
This book convinced me remove my fillings. More...
World's Best Multi
Super Supplemental - Full-Spectrum Multivitamin/Mineral/Herbal SupplementThis is what we use!
The only multi where you feel the difference. More...
Understand Hair Tests
Hair Test Interpretation: Finding Hidden Toxicities by Dr. Andrew CutlerHair Tests Explained!
Discover hidden toxicities, easily. More...
GABA
GABA (gamma-aminobutyric acid)Have Racing Thoughts?
Many use GABA for anxiety and better sleep. More...
Pet Health Charts
Pet Health Charts for Dogs, Cats, Horses, and BirdsHelp Them!
Natural health for pets. More...
The Companion Bible (Hardcover)
The Companion BibleThe Bible We Use!
King James with study notes by Bullinger. More...
The Companion Bible (Softcover)
The Companion BibleThe Bible We Use!
King James with study notes by Bullinger. More...
Sweet Remedy
Sweet RemedyFood Additives
Protect your family from toxic food! More...
Previous Thread
Next Thread
Print Thread
Rating: 5
American Dental Association (ADA) Patents on Dental Amalgam #17545
04/08/07 04:55 PM
04/08/07 04:55 PM
Russ  Online Content
OP
Master Elite Member
Joined: Dec 1999
Posts: 30,793
Maine, USA ****
Please link to this page using this simple URL:
http://urlbam.com/ha/M002e


At least two patents on dental amalgam exists. They are:
  • U.S. Patent 4,018,600 April 1977
  • U.S. Patent 4,078,921 March 1978

They are both assigned to

American Dental Association
Health Foundation
(Chicago, IL)


Below are graphics containing the full text of the patents.

Patent 4,018,600

[Linked Image]

[Linked Image]

[Linked Image]


Patent 4,078,921

[Linked Image]

[Linked Image]

[Linked Image]

[Linked Image]

[Linked Image]


Full Text for Patent 4,018,600

Quote

United States Patent 4,018,600
Waterstrat April 19, 1977
Method for eliminating gamma.sub.2 phase from dental amalgam and improved dental amalgam composition

Abstract

An improved alloy for a dental amalgam includes silver and tin and the additional element, manganese. The alloy is comprised of a minimum of about 60% by weight silver, a maximum of about 15% by weight manganese and the balance tin. Various amounts of other constituents known to those in the art such as gold, copper, zinc and mercury may be included.
Inventors: Waterstrat; Richard M. (Gaithersburg, MD)
Assignee: American Dental Association Health Foundation (Chicago, IL)
Appl. No.: 05/617,594
Filed: September 29, 1975

Current U.S. Class: 420/501 ; 420/527
Current International Class: C22C 5/06 (20060101); C22C 7/00 (20060101); A61K 6/05 (20060101); A61K 6/02 (20060101); C22C 005/06 (); C22C 007/00 ()
Field of Search: 75/173R,169
References Cited [Referenced By]
U.S. Patent Documents

3762917 October 1973 Johnson
Foreign Patent Documents

45-8552 Mar., 1970 JA
Primary Examiner: Rutledge; L. Dewayne
Assistant Examiner: Weise; E. L.
Attorney, Agent or Firm: Allegretti, Newitt, Witcoff & McAndrews
Government Interests


The invention described herein was made in the course of work under a grant or award from the Department of Health, Education and Welfare.
Claims


What is claimed is:

1. An improved alloy for dental amalgam consisting essentially of about 62% by weight silver, about 12% by weight manganese and the balance tin.

2. An improved alloy for dental amalgam consisting essentially of about 66% by weight silver, about 8% by weight manganese and the balance tin.

3. A dental amalgam consisting essentially of an alloy including a minimum of 60% by weight silver and about 2% to a maximum of 15% by weight manganese and the balance tin; in combination with mercury.

4. An improved method for making a dental amalgam comprising the steps of mixing mercury with an alloy, said alloy consisting essentially of a minimum of 60% by weight silver, about 2% to a maximum of 15% by weight manganese and the balance tin.

5. The improved method of claim 4 wherein the weight ratio of said mercury to said alloy is about 1:1 or greater than 1:1.
Description


BACKGROUND OF THE INVENTION

This invention relates to an alloy for a dental amalgam and, more particularly, to a new class of such alloys which include silver, tin and manganese.

Amalgams are presently the principal material used by dentists for restoration of decayed teeth. About 75% of dental restorations are by amalgams. Amalgams are plastic at normal room and body temperature for a few minutes before they harden. Little or no change in volume occurs as a result of becoming hard. Amalgams combine the characteristics of high compressive and moderate tensile strength with the ability to withstand the corrosive environment defined by the mouth. Additionally, they are substantially non-toxic.

Generally, the alloy from which amalgams are made includes a mixture of silver and tin. The American Dental Association has established various standards for such alloys. Following is the American Dental Association specification for compositions of alloys used in making amalgams:

______________________________________ Silver Tin Copper Zinc Mercury ______________________________________ Min wt Max wt Max wt Max wt Max wt % % % % % 65 29 6 2 3 ______________________________________

The above composition standard was adopted by the American Dental Association effective June 1, 1970 and is also identified as American National Standard No. Z156.1-1970. Incorporated herewith by reference is the publication entitled "Guide to Dental Materials and Devices," Seventh Edition 1974-1975, copyright 1974, American Dental Association. Particular attention is directed to chapter 3 of this reference entitled "Amalgam and Mercury" as well as Specification No. 1 of the A.D.A. specifications for dental materials.

Amalgam alloys complying with present specifications and standards are generally silver-tin alloys containing approximately three parts of silver and one part of tin. This alloy is often referred to as the gamma phase (.gamma.) or Ag.sub.3 Sn. In practice, the powdered alloy and mercury are subjected to trituration, thereby facilitating a reaction between mercury and the alloy. The mercury combines with the alloy to form new solid phases from the pulverized or triturated amalgam.

The chemical reaction during amalgamation may be described as follows:

Thus, in addition to a gamma.sub.1 phase (.gamma.) (Ag.sub.2 Hg.sub.3), a tin-mercury phase, often referred to as the gamma.sub.2 phase (.gamma..sub.2), is formed. The gamma.sub.2 phase has a simple hexagonal crystal structure and may contain 5 to 12% atomic percent mercury. The designation for this phase is uncertain; though, the phase is often designated as Sn.sub.7 Hg or Sn.sub.8 Hg.

The tin-mercury phase in a dental amalgam is known as a weak constituent relative to the silver-tin and silver-mercury phases. Nonetheless, the gamma.sub.2 phase may comprise up to 10% of the amalgam. The gamma.sub.2 phase has been associated with poor corrosion resistance and excessive flow or creep under an applied stress. To overcome the deficiencies noted in the gamma.sub.2 phase, the subject matter of the present invention has been developed.

SUMMARY OF THE INVENTION

Briefly, the invention comprises an improved alloy for amalgams wherein manganese is used in silver-tin based dental alloys to react with the tin during amalgamation and thus reduce or eliminate the tendency of these alloys to form the undesirable gamma.sub.2 phase.

Thus, it is an object of the present invention to provide an improved alloy for dental amalgams.

It is a further object of the present invention to provide an improved alloy for dental amalgams utilizing manganese in order to improve corrosion resistance and reduce excessive flow or creep.

Still another object of the present invention is to provide an improved alloy for dental amalgams which is inexpensive and effective with an ability to perform acceptably and meet standard specifications.

These and other objects, advantages and features will be set forth in the detailed description which follows.

DESCRIPTION OF THE PREFERRED EMBODIMENT

The alloy of the present invention utilizes manganese in combination with a silver-tin dental alloy. The manganese reacts with the tin during the amalgamation process, thus reducing or eliminating the tendency of such alloys to form the undesirable gamma.sub.2 phase during amalgamation.

As an example of the particular class of compounds which result during the amalgamation of the alloy, the following formulation is set forth:

The relative amounts of Ag.sub.2 Hg.sub.3 and MnSn.sub.2 which are formed depend upon the amount of manganese. If no manganese is present, then the reaction which occurs is the standard amalgam reaction recited above in the Background of the Invention. Increased amounts of manganese will decrease progressively the amount of tin which is available to form the gamma.sub.2 phase.

Typically, in such alloys, an amount of the original alloy particles (Ag.sub.3 Sn) remains unreacted. Thus, one normally obtains a solid mixture of the products of the reaction together with residual, unreacted alloy particles. A certain amount of manganese remains in the unreacted portion and thus available for reaction with tin. It is therefore difficult to predict exactly how much manganese is needed to prevent the formation of the gamma.sub.2 phase. A lower limit of the amount, however, can be calculated by assuming that all the manganese is available for reaction. On this base, it is estimated that about 8% manganese should suffice to eliminate all the gamma.sub.2 phase; however, experience indicates that manganese in an amount of 2% by weight to a maximum of 15% by weight is efficacious in the practice of the invention.

Additions of manganese in excess of the amount required to eliminate the gamma.sub.2 phase may provide beneficial effects. Alloys have been tested containing 12% manganese. Such alloys possessed excellent resistance to creep or flow as compared with an 8% manganese alloy of the present invention or with other commercial amalgam alloys. Tests also indicate that amalgams prepared from the above-described alloys are equally as corrosion resistant as other commercial alloys. Following are examples of alloys and specific tests performed:

EXAMPLE No. 1

Homogeneous mixture comprising 62% silver, 12% manganese and 26% tin was prepared by atomization of the molten metal alloy. This resulted in the formation of approximately spherical particles having a particle size between 325 and 400 mesh. An amalgam was prepared from the alloy using a 6.2:6 ratio of mercury to alloy. The amalgam was prepared in a commercial amalgamator in accordance with conventional procedures. All tests were conducted using methods described in the American Dental Association specification No. 1 referenced above. Corrosion resistance was determined to be as good as any of the prior art amalgams. Resistance to creep or flow was improved relative to prior art amalgams. Typical comparative data is set forth below with the amalgam of the 12% alloy of the present invention listed first:

__________________________________________________________________________ Dimensional 24 hr. Diam..sup.3 Alloy ADA Flow Test.sup.1 Change Tensile Strength __________________________________________________________________________ 12% Mn alloy 0.16 to 0.03% 0 to +4 5700 to 7500 psi Dispersalloy.sup.4 0.6% +13 7300 psi 10% Au alloy +20 7750 to 8900 psi Optalloy.sup.5 1.09% -7 10,700 to 11,100 psi Velvalloy.sup.6 0.81% -12 Spheralloy.sup.7 0.86% -17 __________________________________________________________________________

______________________________________ 15 min. Diam..sup.2 Alloy Tensile Strength ______________________________________ 12% Mn alloy 1760-1970 psi Dispersalloy 300 psi Optalloy 800 psi Velvalloy 550 psi Spheralloy 650 psi ______________________________________

This amalgam was sectioned, polished and submitted to examination by X-ray area scanning in an electron microprobe. The characteristic X-ray emission from tin, manganese and silver was mapped separately on the same area of the sample at a magnification of about 1000X. This technique revealed that each residual spherical particle of the gamma.sub.1 phase was surrounded by a layer of manganese-tin compound. There was no evidence of any tin-mercury compound. X-ray diffraction patterns of this amalgam were difficult to interpret due to line overlaps but the strong-intensity line of the gamma phase, usually present in patterns from conventional amalgams, was in this case replaced by a weak-intensity line.

1. American Dental Association Specification No. 1 flow test.

2. American Dental Association Specification No. 1 tensile strength.

3. The same test as defined by No. 2, except after 24 hours.

4. Trade name for amalgam alloy sold by American Silver & Mercury Producers.

5. Trade name for amalgam alloy sold by L. D. Caulk Co., Division of Dentsply International, Inc.

6. Trade name for amalgam alloy sold by S. S. White Division, Pennwalt Corp.

7. Trade name for amalgam alloy sold by Ken Mfg. Co.

EXAMPLE NO. 2

The same experiment was performed using an alloy including 66% silver, 8% manganese and 26% tin. Substantially identical results were observed.

It is clear that changes to the composition may be effected and still remain within the scope of the invention. Thus, the amalgamation procedure may call for additional mercury. Other alloying agents such as copper, zinc or mercury may be included in the alloy. The invention therefore is to be limited only by the following claims and their equivalents.



Full Text for Patent 4,078,921

Quote

United States Patent 4,078,921
Waterstrat March 14, 1978
Method for eliminating gamma.sub.2 phase from dental amalgam and improved dental amalgam composition

Abstract

An improved alloy for a dental amalgam includes silver and tin and the additional element, manganese. The alloy is comprised of a minimum of about 60% by weight silver, a maximum of about 20% by weight manganese and the balance tin. Various amounts of other constituents known to those in the art such as gold, copper, zinc and mercury may be included.
Inventors: Waterstrat; Richard M. (Gaithersburg, MD)
Assignee: American Dental Association Health Foundation (Washington, DC)
Appl. No.: 05/713,849
Filed: August 12, 1976
Related U.S. Patent Documents

Application Number Filing Date Patent Number Issue Date
617594 Sep., 1975 4018600

Current U.S. Class: 420/501 ; 420/527
Current International Class: C22C 5/06 (20060101); C22C 7/00 (20060101); A61K 6/05 (20060101); A61K 6/02 (20060101); C22C 005/06 (); C22C 007/00 ()
Field of Search: 75/173R,173C,169
References Cited [Referenced By]
U.S. Patent Documents

1970319 August 1934 Kern
3954457 May 1976 Weikel
3997328 December 1976 Greener
3997329 December 1976 Aliotta et al.
4018600 April 1977 Waterstrat
Foreign Patent Documents

949,063 Aug., 1949 FR
8,552 Mar., 1970 JA
112,902 Jan., 1945 SW
Primary Examiner: Lovell; C.
Attorney, Agent or Firm: Allegretti, Newitt, Witcoff & McAndrews
Government Interests


The invention described herein was made in the course of work under a grant or award from the Department of Health, Education and Welfare.
Parent Case Text


This is a continuation-in-part of copending application Ser. No. 617,594, filed Sept. 19, 1975, now U.S. Pat. No. 4,018,600.
Claims


What is claimed is:

1. An improved alloy for a dental amalgam consisting essentially of at least 2% up to 20% by weight manganese and the balance 60-83% by weight silver and 16-29% by weight tin.

2. An alloy as set forth in claim 1 including 1-5% mercury as a preamalgam.

3. An alloy as set forth in claim 1 including one or more from the group of gold and copper in place of part of the manganese.

4. An alloy as set forth in claim 1 in combination with mercury to form an amalgam.
Description


BACKGROUND OF THE INVENTION

This invention relates to an alloy for a dental amalgam and, more particularly, to a new class of such alloys which include silver, tin and manganese.

Amalgams are presently the principal material used by dentists for restoration of decayed teeth. About 75% of dental restorations are by amalgams. Amalgams are plastic at normal room and body temperature for a few minutes before they harden. Little or no change in volume occurs as a result of becoming hard. Amalgams combine the characteristics of high compressive and moderate tensile strength with the ability to withstand the corrosive environment defined by the mouth. Additionally, they are substantially non-toxic.

Generally, the alloy from which amalgams are made includes a mixture of silver and tin. The American Dental Association has established various standards for such alloys. Following is the American Dental Association specification for compositions of alloys used in making amalgams:

______________________________________ Silver Tin Copper Zinc Mercury Min wt Max wt Max wt Max wt Max wt % % % % % 65 29 6 2 3 ______________________________________

The above composition standard was adopted by the American Dental Association effective June 1, 1970 and is also identified as American National Standard No. Z156.1-1970. Incorporated herewith by reference is the publication entitled "Guide to Dental Materials and Devices", Seventh Edition 1974- 1975, copyright 1974, American Dental Association. Particular attention is directed to chapter 3 of this reference entitled "Amalgam and Mercury" as well as Specification No. 1 of the A.D.A. specifications for dental materials.

Amalgam alloys complying with present specifications and standards are generally silver-tin alloys containing approximately three parts of silver and one part of tin. This alloy is often referred to as the gamma phase (.gamma.) or Ag.sub.3 Sn. In practice, the powdered alloy and mercury are subjected to trituration, thereby facilitating a reaction between mercury and the alloy. The mercury combines with the alloy to form new solid phases from the pulverized and triturated amalgam.

The chemical reaction during amalgamation may be described as follows:

Thus, in addition to a gamma.sub.1 phase (.gamma..sub.1) (Ag.sub.2 Hg.sub.3), a tin-mercury phase, often referred to as the gamma.sub.2 phase (.gamma..sub.2), is formed. The gamma.sub.2 phase has a simple hexagonal crystal structure and may contain 5 to 12% atomic percent mercury. The composition for this phase is uncertain; though, the phase is often designated as Sn.sub.7 Hg or Sn.sub.8 Hg.

The tin-mercury phase in a dental amalgam is known as a weak constituent relative to the silver-tin and silver-mercury phases. Nonetheless, the gamma.sub.2 phase may comprise up to 10% of the amalgam. The gamma.sub.2 phase has been associated with poor corrosion resistance and excessive flow or creep under an applid stress. To overcome the deficiencies noted in the gamma.sub.2 phase, the subject matter of the present invention has been developed.

SUMMARY OF THE INVENTION

Briefly, the invention comprises an improved alloy for amalgams wherein manganese is used in silver-tin based dental alloys to react with the tin during amalgamation and thus reduce or eliminate the tendency of these alloys to form the undesirable gamma.sub.2 phase.

Thus, it is an object of the present invention to provide an improved alloy for dental amalgams.

It is a further object of the present invention to provide an improved alloy for dental amalgams utilizing manganese in order to improve corrosion resistance and reduce excessive flow or creep.

Still another object of the present invention is to provide an improved alloy for dental amalgams which is inexpensive and effective with an ability to perform acceptably and meet standard specifications.

These and other objects, advantages and features will be set forth in the detailed description which follows.

DESCRIPTION OF THE PREFERRED EMBODIMENT

The alloy of the present invention utilizes manganese in combination with a silver-tin dental alloy. The manganese reacts with the tin during the amalgamation process, thus reducing or eliminating the tendency of such alloys to form the undesirable gamma.sub.2 phase during amalgamation.

As an example of the particular class of compounds which result during the amalgamation of the alloy, the following formulation is set forth:

The relative amounts of Ag.sub.2 Hg.sub.3 and MnSn.sub.2 (MnSn, Mn.sub.2 Sn) which are formed depend upon the amount of manganese. If no manganese is present, then the reaction which occurs is the standard amalgam reaction recited above in the Background of the Invention. Increased amounts of manganese will decease progressively the amount of tin which is available to form the gamma.sub.2 phase.

Typically, in such alloys, an amount of the original alloy particles (Ag.sub.3 Sn) remains unreacted. Thus, one normally obtains a solid mixture of the products of the reaction together with residual, unreacted alloy particles. A certain amount of manganese remains in the unreacted portion and thus unavailable for reaction with tin. It is therefore difficult to predict exactly how much manganese is needed to prevent the formation of the gamma.sub.2 phase. A lower limit of the amount, however, can be calculated by assuming that all of the manganese is available for reaction. On this basis, it is estimated that about 8% manganese should suffice to eliminate the gamma.sub.2 phase.

Additions of manganese in excess of the amount required to eliminate the gamma.sub.2 phase may provide beneficial effects. Alloys have been tested containing 12% manganese. Such alloys possessed excellent resistance to creep or flow as compared with an 8% manganese alloy of the present invention or with other commercial amalgam alloys. Preliminary tests also indicate that amalgams prepared from the above-described alloys are equally as corrosion resistant as other commercial alloys. Following are examples of alloys and specific tests performed:

EXAMPLE No. 1

Homogeneous mixture comprising 62% silver, 12% manganese and 26% tin was prepared by atomization of the molten metal alloy. This resulted in the formation of approximately spherical particles having a particle size between 325 and 400 mesh. An amalgam was prepared from the alloy using a 6.2:6 ratio of mercury to alloy. The amalgam was prepared in a commercial amalgamator in accordance with conventional procedures. All tests were conducted using methods described in the American Dental Association specification No. 1 referenced above. Corrosion resistance was determined to be as good as many of the prior art amalgams. Resistance to creep or flow was improved relative to prior art amalgams. Typical comparative data is set forth below with the amalgam of the 12% alloy of the present invention listed first:

__________________________________________________________________________ Dimensional 24 hr. Diam..sup.3 Alloy ADA Flow Test.sup.1 Change Tensile Strength __________________________________________________________________________ 12% Mn alloy 0.16 to 0.03% 0 to +4 5700 to 7500 psi Dispersalloy.sup.4 0.6% +13 7300 psi 10% Au alloy +20 7750 to 8900 psi Optalloy.sup.5 1.09% -7 10,700 to 11,100 psi Velvalloy.sup.6 0.81% -12 Spheralloy.sup.7 0.86% -17 __________________________________________________________________________ 15 min. Diam..sup.2 Alloy Tensile Strength __________________________________________________________________________ 12% Mn alloy 1760-1970 psi Dispersalloy 300 psi Optalloy 800 psi Velvalloy 550 psi Spheralloy 650 psi __________________________________________________________________________

This amalgam was sectioned, polished and submitted to examination by X-ray area scanning in an electron microprobe. The characteristic X-ray emission from tin, manganese and silver was mapped separately on the same area of the sample at a magnification of about 1000X. This technique revealed that each residual spherical particle of the gamma.sub.1 phase was surrounded by a layer of manganese-tin compound. There was no evidence of any tin-mercury compound. X-ray diffraction patterns of this amalgam were difficult to interpret dut to line overlaps but the strong-intensity line of the gamma.sub.2 phase, usually present in patterns from conventional amalgams, was in this case replaced by a weak-intensity line.

1. American Dental Association Specification No. 1 flow test.

2. American Dental Association Specification No. 1 tensile strength.

3. The same test as defined by No. 2, except after 24 hours.

4. Trade name for amalgam alloy sold by America Silver & Mercury Producers.

5. Trade name for amalgam alloy sold by L. D. Caulk Co., Division of Dentsply International, Inc.

6. Trade name for amalgam alloy sold by S. S. White Division, Pennwalt Corp.

7. Trade name for amalgam alloy sold by Kerr Mfg. Co.

EXAMPLE No. 2

The same experiment was performed using an alloy including 66% silver, 8% manganese and 26% tin. Substantially identical results were observed.

Additional experiments have shown that the amount of manganese may be increased to 20% by weight without adversely affecting the efficacy of the invention. Moreover, it is also possible to mix the improved manganese alloy with previously existing amalgam alloys to achieve the improvement of the invention. For example, a prior art alloy including a minimum of 65% by weight silver, a maximum of 29% by weight tin, a maximum of 6% by weight copper, a maximum of 2% by weight zinc and a maximum of 3% by weight mercury may be combined with the alloy of the present invention.

This mixture of alloys may then be formed as an amalgam by proper trituration of mercury and the two alloys. The permitted ratio of the two alloys extends over the full range of possible mixtures. A preferred ratio provides an effective amount of manganese equal to about 10 to 12% of the total weight of the mixed alloys.

The improved manganese alloy of the present invention may also be mixed with more than one additional dental alloy. Thus, two or more dental amalgam alloys may be mixed with the improved alloy of the present invention to provide a composite alloy formable as an amalgam by proper trituration.

Additionally, the manganese component of the alloy of the present invention may be replaced, in part, by copper or gold. For example, about one to thirty parts by weight copper may be substituted for part of the manganese and/or silver.

The alloy may also be preamalgamated. That is, the alloy may contain a small percentage (1-5% by weight) of mercury. This mercury is included as part of the alloy before amalgamation. The preamalgamated alloy may then be formed as an amalgam by proper trituration of additional mercury and the alloy.

In summary, the contemplated range of alloy constituents is set forth below.

______________________________________ Range (by weight) Preferred (by weight) ______________________________________ Tin (Sn) - 16-29% 26 .+-. 0.1% Silver (Ag) - 60-83% about 65 .+-. 3% Manganese (Mn) - 2%-20% about 10 .+-. 3% Copper (Cu) - 1-30% as a substitute for part of the manganese and/or silver Mercury (Hg) - 1-5% as a preamalgam Gold (Au) - 1-10% as a substitute for part of the manganese and/or silver ______________________________________

It is clear that changes to the composition may be effected and stil remain within the scope of the invention. Thus, the amalgamation procedure may call for additional mercury. Other alloying agents such as copper, zinc or mercury may be included in the alloy. The invention, therefore, is to be limited only by the following claims and their equivalents.



The Captian
Today they call you "crazy". Tomorrow they call you "ahead of your time."
Global Skywatch Learn about Chemtrails - You're breathing them now!
OnlyTheBestHerbs.com World-class supplements
Mercury Talk Why you are sick.
OneUp Domains Domains, Hosting, Email
1-800-358-4278 (U.S. & Canada)
Re: American Dental Association (ADA) Patents on Dental Amalgam #17546
04/08/07 06:53 PM
04/08/07 06:53 PM
SoSick  Offline
Master Elite Member
Joined: Apr 2007
Posts: 2,153
Lost on a mountain USA ***
yup.

and here's the logic by which they make decsions:

$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$



and that type of logic is very difficult to argue with.

Re: American Dental Association (ADA) Patents on Dental Amalgam #17547
04/08/07 07:01 PM
04/08/07 07:01 PM
Bex  Offline
Master Elite Member
Joined: Jun 2006
Posts: 4,178
NZ ****
Sadly sosick, you are right. It is about the big $. What a world.

Re: American Dental Association (ADA) Patents on Dental Amalgam #17548
04/09/07 12:26 AM
04/09/07 12:26 AM
A
asus  Offline
Junior Member
Joined: Oct 2006
Posts: 46
You know I overheard an interesting conversation from a relative the other day. They are a dentist, and while they no longer place amalgams, they aren't "mercury free" perse in that they specialize in replacing them etc... They told me they went to a dentistry seminar, and one of the speakers mentioned he thought amalgam would be "phased out" in the USA in the next 5 years. The primary reason? Sweden banned Amalgam, and much of the mercury to make amalgam is mined in Europe, which is also entertaining an EU wide ban on mercury export by or around 2010, so the US companies won't be able to import it anymore. Not sure how accurate the statement was, but its interesting nonetheless...

Re: American Dental Association (ADA) Patents on Dental Amalgam #17549
04/09/07 04:46 PM
04/09/07 04:46 PM
A
Anonymous
Unregistered

If the patents are from 1978, they expired years ago.

Re: American Dental Association (ADA) Patents on Dental Amalgam #17550
04/09/07 11:01 PM
04/09/07 11:01 PM
SoSick  Offline
Master Elite Member
Joined: Apr 2007
Posts: 2,153
Lost on a mountain USA ***
Under certain circumstance perhaps, but I checked and these are listed as current (not expired) at the USPTO.

You can search for more patents owned by the American Dental Association here:

http://patft.uspto.gov/netahtml/PTO/search-bool.html

Type 'American dental association' in the Term 1 field, scroll to Assignee name in the Field 1 drop down and then click 'Search'.


Re: American Dental Association (ADA) Patents on Dental Amalgam #17551
04/10/07 01:31 PM
04/10/07 01:31 PM
A
Anonymous
Unregistered

No patents are good for 29 years

Re: American Dental Association (ADA) Patents on Dental Amalgam #17552
04/13/07 01:26 AM
04/13/07 01:26 AM
Russ  Online Content
OP
Master Elite Member
Joined: Dec 1999
Posts: 30,793
Maine, USA ****
I know little about the expiration times of patents, but would love to find out. If you have information, please post it.

Nevertheless, the prevailing question is, how much money did they make off of our illnesses and suffering?


The Captian
Today they call you "crazy". Tomorrow they call you "ahead of your time."
Global Skywatch Learn about Chemtrails - You're breathing them now!
OnlyTheBestHerbs.com World-class supplements
Mercury Talk Why you are sick.
OneUp Domains Domains, Hosting, Email
1-800-358-4278 (U.S. & Canada)
Re: American Dental Association (ADA) Patents on Dental Amalgam #17553
04/13/07 02:10 PM
04/13/07 02:10 PM
A
Anonymous
Unregistered

I nam a member of the state bar of Calif and a graduate of one of the top law schools in the country.

Re: American Dental Association (ADA) Patents on Dental Amalgam #17554
04/13/07 03:37 PM
04/13/07 03:37 PM
Elvis  Offline
Advanced Master Member
Joined: Mar 2007
Posts: 448 ****
thats very impwessive! And medical school, too! But could you just answer the question ( cuz that could be interesting.)
many thanks

Re: American Dental Association (ADA) Patents on Dental Amalgam #17555
04/13/07 03:54 PM
04/13/07 03:54 PM
SomedaySoon  Offline
Master Member
Joined: May 2006
Posts: 326 *****
Actually, some patents can still be in existence at 29 years because the "inventors" or companies holding the patents can apply for patent extensions. Also, the patented product can be tweaked or altered, if you will, for which a new patent can be applied. An example would be adding a new ingredient or altering an existing ingedient in a formulation.

Typically, utility patents have a term or "life" of 20 years from the date of filing of the patent application on which the patent issued, and design patents have a term of 14 years. But note that utility patents require the payment of maintenance fees to remain in force, while design patents do not require the payment of maintenance fees. Maintenance fees will be due three and a half, seven and a half and eleven and a half years later years after the grant of the utility patent.

What's the difference between a utility patent and a design patent? . . . Utility patents are typically used to protect a machine that is made from several components arranged to carry out a function, steps of a process, an article of manufacture, or a composition of matter (such as a novel chemical composition, for example). Design patents are issued for ornamental designs on articles of manufacture. Example: the aesthetic features of a cellular phone case.

Anyway, coincidentally, I saw this article today while reading news articles.

Big Pharma teaches old drugs new tricks
Drugmakers hunt for new patents on old blockbusters to try and postpone the inevitable: generic competition.
By Aaron Smith, CNNMoney.com staff writer
March 21 2007: 3:04 PM EDT

NEW YORK (CNNMoney.com) -- As Big Pharma faces patent expirations on some of its most lucrative drugs, the industry is trying to reinvigorate sales by finding creative ways to land new patents - but on the same old drugs.

The industry is losing some $16 billion worth of annual sales this year because of patents that will expire; last year it suffered $23 billion in patent losses, according to the research firm IMS Health. And despite clever reformulations of popular patented drugs like Lipitor and Zyrtec, Pfizer (up $0.13 to $25.67, Charts) and other industry leaders are discovering that there is no substitute for the ever-elusive new blockbusters.

But since new blockbusters are hard to find, drug companies are tweaking their existing drugs -- by creating extended release versions for instance -- in order to get new patents on old drugs. Drugmakers are also combining drugs whose patents are set to expire with other drugs to create entirely new products, and new patents. These patent-extension tricks certainly help to cushion the blow of the sales vacuum created by patent expirations, but they're no substitute for new products worth billions.

Les Funtleyder, analyst for Miller Tabak, said that Big Pharma is paying the price for its "innovative black hole," and has "relatively few tools in the tool kit" to address the impending post-patent sales dips.

"At some point, all big drugs are going to go off patent, and the question is: What does Big Pharma do next?" said Funtleyder. "They could innovate their way out of the problem, or they could buy a pipeline, or they could go out of business."

Pfizer's patent for Norvasc, the company's second-biggest drug, expires in September. That marks the beginning of the end for a blood pressure drug that racked up nearly $5 billion in 2006 sales. In the year after a drug patent expires, sales typically plunge 80 percent as generic drugmakers produce competing, low-cost versions.

But Pfizer, the New York-based drug giant, has put a new spin on Norvasc by combining it with Lipitor, the cholesterol-lowering drug that's also the industry's biggest seller, with nearly $13 billion in 2006 sales. The resulting combo, called Caduet, totaled $370 million in 2006 sales, a figure that pales in comparison to the nearly $18 billion in combined annual sales for Lipitor and Norvasc.

"With a product like [Norvasc], you just have to take the hit," said James McKean, analyst for Atlantic Equities. "They tried to shift prescriptions to Caduet, a combo of Norvasc and Lipitor, but it hasn't been all that successful."
Medical companies take fantastic voyage to heart

Pfizer's patent on its allergy blockbuster Zyrtec is also set to expire in September, and the company is trying to protect those sales with a patented spin-off called Zyrtec-D, an extended-release version of the drug.

"[Zyrtec-D] has helped to protect some of the brand, but it doesn't protect the whole thing," said McKean of Atlantic Equities. "It's a slightly less precipitous fall, but you [still] expect a sales decline."

The impact of Zyrtec-D on company sales isn't exactly clear. Pfizer reported more than $1.5 billion in 2006 sales for its Zyrtec franchise, but didn't break out revenue for the extended release version.

Other companies have protected sales through drug combinations. Merck (up $0.37 to $44.00, Charts), the New Jersey-based drugmaker, combined Zocor, an anti-cholesterol blockbuster that lost patent protection in 2006, with Schering-Plough's (up $0.56 to $24.31, Charts) cholesterol drug Zetia. The combination totaled nearly $4 billion in 2006 sales, which was divided between Merck and Schering-Plough.

New Jersey-based Schering-Plough has been particularly successful in protecting sales using patent extensions. When the company lost its patent on the antihistamine blockbuster Claritin in 2002, it protected those sales by launching a generic over-the-counter version of the allergy drug Claritin RX, and also launched a tweaked prescription version called Clarinex. Clarinex sales totaled $722 million in 2006 and OTC Claritin sales totaled $356 million. That total is a fraction of Claritin's $3 billion-a-year sales history, but it exceeds the billion-dollar mark that distinguishes a blockbuster.

GlaxoSmithKline (up $0.31 to $55.93, Charts) has also added patents to try and ward off a sales plunge. The British drugmaker lost the patent on its former blockbuster antidepressant Paxil in 2003, but still managed to glean more than $600 million in 2006 sales with new, tweaked versions of the drug.

Indeed drug companies' products consistently come under assault from generic drugmakers even before their patents expire. On Tuesday, Pfizer successfully defended in a New Jersey court three patents on its arthritis painkiller Celebrex, worth more than $2 billion in 2006 sales, against a challenge by the biggest generic drug giant in the world: the Israeli company Teva Pharmaceuticals (up $0.38 to $36.96, Charts). The court ruling bars Teva from producing a generic version of Celebrex until the patent runs out in 2015.

Bristol-Myers Squibb (up $0.45 to $27.60, Charts) suffered a similar assault on its anti-clotting blockbuster drug Plavix in 2006, when the privately-held Canadian company Apotex flooded the market with a low-cost generic version of Plavix despite the fact that the patent doesn't expire until 2012.
Cashing in on 'orphans'

Bristol managed to get Apotex legally blocked from continuing to produce the generic, but not before sustaining a 53 percent hit to Plavix sales in the fourth quarter, down to $496 million. Plavix sales totaled $3.4 billion in 2006, down 15 percent from the year before. This was the final straw in a string of failures and missteps that led to the ouster of Bristol's former chief executive Peter Dolan.

Big Pharma's battles to extend and protect its drug patents are hard-fought, but they ultimately cannot compensate for a weak research and development pipeline.

Miller Tabak analyst Funtleyder of compared the drug companies' methods of extending patents and creating partnerships to "rearranging deck chairs on the Titanic."

"You should never look revenue in the mouth, but the key driver on pharma is new products," said Funtleyder.


SomedaySoon (Sharon)

Re: American Dental Association (ADA) Patents on Dental Amalgam #17556
04/15/07 06:20 PM
04/15/07 06:20 PM
A
Anonymous
Unregistered

There is no such thing as an extension on a substance that has already received a patent. If a new version of an existing drug is not significantly different from an existing drug ,a patent on the new substance will be denied . This happens all the time even to Pfizer etc. While I'm not Robert Bork ,I did take intellectual property.

Re: American Dental Association (ADA) Patents on Dental Amalgam #17557
04/16/07 02:08 AM
04/16/07 02:08 AM
Russ  Online Content
OP
Master Elite Member
Joined: Dec 1999
Posts: 30,793
Maine, USA ****
How long do patents last?


The Captian
Today they call you "crazy". Tomorrow they call you "ahead of your time."
Global Skywatch Learn about Chemtrails - You're breathing them now!
OnlyTheBestHerbs.com World-class supplements
Mercury Talk Why you are sick.
OneUp Domains Domains, Hosting, Email
1-800-358-4278 (U.S. & Canada)
Re: American Dental Association (ADA) Patents on Dental Amalgam #17558
04/16/07 02:25 PM
04/16/07 02:25 PM
SomedaySoon  Offline
Master Member
Joined: May 2006
Posts: 326 *****
Hi Russ,

I'm certainly no patent lawyer. But this is what I've found. Typical patent term is 20 years from what I'm seeing. Then again, not all patented materials/items are "typical." Here is a website that has a good explanation on Pharma-type patents and patent extensions.

http://www.fda.gov/cder/about/smallbiz/patent_term.htm

And from the US Patent and Trademark Office Website:

http://www.uspto.gov/web/offices/pac/doc/general/index.html#whatpat



Nature of Patent and Patent Rights

. . . The patent is issued in the name of the United States under the seal of the United States Patent and Trademark Office, and is either signed by the Director of the USPTO or is electronically written thereon and attested by an Office official. The patent contains a grant to the patentee, and a printed copy of the specification and drawing is annexed to the patent and forms a part of it. The grant confers “the right to exclude others from making, using, offering for sale, or selling the invention throughout the United States or importing the invention into the United States” and its territories and possessions for which the term of the patent shall be generally 20 years from the date on which the application for the patent was filed in the United States or, if the application contains a specific reference to an earlier filed application under 35 U.S.C. 120, 121 or 365(c), from the date of the earliest such application was filed, and subject to the payment of maintenance fees as provided by law.

The term of the patent shall be generally 20 years from the date on which the application for the patent was filed in the United States or, if the application contains a specific reference to an earlier filed application under 35 U.S.C. 120, 121 or 365(c), from the date of the earliest such application was filed, and subject to the payment of maintenance fees as provided by law. A maintenance fee is due 3 1/2, 7 1/2 and 11 1/2 years after the original grant for all patents issuing from the applications filed on and after December 12, 1980. The maintenance fee must be paid at the stipulated times to maintain the patent in force. After the patent has expired anyone may make, use, offer for sale, or sell or import the invention without permission of the patentee, provided that matter covered by other unexpired patents is not used. The terms may be extended for certain pharmaceuticals and for certain circumstances as provided by law.

********
ALso from the US Patent website a link to Laws and Regulations:

http://www.uspto.gov/web/patents/legis.htm

SomedaySoon



Re: American Dental Association (ADA) Patents on Dental Amalgam #17559
04/26/07 06:03 PM
04/26/07 06:03 PM
A
Anonymous
Unregistered

Thank you for your opinion Sharon Day O'Conner. However, I stand by my original statement that all patents have expired before twenty nine years.
So called patent extensions are not really extensoins because the owners of certain patents such as drugs are not able to profit from their inventions until they receive FDA approval even though a patent has been granted.Patents are anticompetitive.They are monopolies that don't violate the Sherman antitrust act. This.provision is irrelevant re amalgam patents. Even where it applies ,it has to be for less than five years and the owner of the patent has to show due diligence.

Re: American Dental Association (ADA) Patents on Dental Amalgam #17560
04/27/07 11:54 PM
04/27/07 11:54 PM
Russ  Online Content
OP
Master Elite Member
Joined: Dec 1999
Posts: 30,793
Maine, USA ****
Is there a way for us to determine exactly when (start to end) these patents were in effect?


The Captian
Today they call you "crazy". Tomorrow they call you "ahead of your time."
Global Skywatch Learn about Chemtrails - You're breathing them now!
OnlyTheBestHerbs.com World-class supplements
Mercury Talk Why you are sick.
OneUp Domains Domains, Hosting, Email
1-800-358-4278 (U.S. & Canada)
Re: American Dental Association (ADA) Patents on Dental Amalgam #17561
05/03/07 01:59 PM
05/03/07 01:59 PM
A
Anonymous
Unregistered

If the patent was granted in 1978 , it expired in 1995.I presume this patent was for the high copper amalgam that releases far more mercury than its predecessor.

Re: American Dental Association (ADA) Patents on Dental Amalgam #17562
05/05/07 12:44 AM
05/05/07 12:44 AM
SoSick  Offline
Master Elite Member
Joined: Apr 2007
Posts: 2,153
Lost on a mountain USA ***
Far as I know, if they are listed as live and active then they are live and active.

dead patents are not kept in the same area.

I have filed trademarks myself and they work the same way essentially, live or dead, no inbetweens.

It probably has an extension filed on it or is indefinitely trying to file for extension, which maintains it's status as live. Either way it is definitely in the live file.

Re: American Dental Association (ADA) Patents on Dental Amalgam #17563
05/06/07 04:25 PM
05/06/07 04:25 PM
Russ  Online Content
OP
Master Elite Member
Joined: Dec 1999
Posts: 30,793
Maine, USA ****
This is interesting. I would love to call a patent attorney and see what their take is on it. Perhaps I will.

I do appreciate both of your persistence on this issue as you both seem to have good points.


The Captian
Today they call you "crazy". Tomorrow they call you "ahead of your time."
Global Skywatch Learn about Chemtrails - You're breathing them now!
OnlyTheBestHerbs.com World-class supplements
Mercury Talk Why you are sick.
OneUp Domains Domains, Hosting, Email
1-800-358-4278 (U.S. & Canada)
Re: American Dental Association (ADA) Patents on Dental Amalgam #17564
05/09/07 04:21 PM
05/09/07 04:21 PM
A
Anonymous
Unregistered

If the patent was granted in 1978, it would be impossible for them to get an extension as I explained above.
Patent law is the only field of law one can't practice with a law degree and state bar membership. In order to be certified as a patent lawyer , one needs to qualify in terms of the number of science units one had in college and professional school and pass the patent bar exam.
Two firms that have patent lawyers are Jones -Day and Sidley -Austin. Both have offices in New York.
Sidley Austin occupied several floors of the world trade center until 2001. When the plane hit ,they acertained that the hit occured above their offices. They were told to stay put until further notice . Instead they decided that since the collision was above them ,they should exit immediately via the stairs. None of the several hundred people working there died. Many people followed the advice from authorities to stay put and are obviously no longer alive . Sidley- Austin is one of the most prestigous firms in the country .Its members are graduates of top twenty law schools . Their behavior on 911 shows the correlation between high IQ and common sense.
I also graduated from a top twenty law school.I recently talked to a man I know who is a blue collar worker who said he would never allow a dentist to do any work on a tooth that did'nt hurt.He has only three fillings, no crowns or root canals . I ,on the other hand have a mouth full of dental work , much of it on teeth that did'nt bother me .Either he has more common sense or I grew up in a sheltered environment and did'nt learn that you can't trust most people.

The Human Average #17565
05/09/07 11:48 PM
05/09/07 11:48 PM
Russ  Online Content
OP
Master Elite Member
Joined: Dec 1999
Posts: 30,793
Maine, USA ****
Quote
Their behavior on 911 shows the correlation between high IQ and common sense.

The dialog about IQ and common sense is about a tendency, not an absolute.

One of the most consistent things I've experienced about people is this:

If a person has a very strong personality point somewhere in the spectrum of human attribute, they have an equally weak one somewhere else.

I've also noticed that people who have several moderately strong points tend to have several moderately weak ones.

It's like this. If you graph a single person's human attributes as X and level of strength or weakness as Y, and then average the amplitude of Y, the value of all people tested generally comes out to be the same, or close to it.

That's fairly consistent in my experience.

Note: The perception of strengths and weaknesses are another story because they are shaped by culture. For the above to work, you have to have a standard and factor the cultural coloration out. This process requires a lot of objectivity, which happens to be one of my strengths. <img src="/ubbthreads/images/graemlins/smile.gif" alt="" />


The Captian
Today they call you "crazy". Tomorrow they call you "ahead of your time."
Global Skywatch Learn about Chemtrails - You're breathing them now!
OnlyTheBestHerbs.com World-class supplements
Mercury Talk Why you are sick.
OneUp Domains Domains, Hosting, Email
1-800-358-4278 (U.S. & Canada)

Powered by UBB.threads™ PHP Forum Software 7.7.1